Bio Essence Corporation
BIOE
$0.0937
$0.00272.97%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 259.10K | 22.20K | 147.60K | 134.70K | 41.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 259.10K | 22.20K | 147.60K | 134.70K | 41.70K |
| Cost of Revenue | 90.50K | 1.60K | 40.70K | 53.70K | 12.50K |
| Gross Profit | 168.60K | 20.60K | 106.90K | 81.00K | 29.20K |
| SG&A Expenses | 107.40K | 225.70K | 103.00K | 227.40K | 194.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 197.90K | 227.30K | 143.70K | 281.10K | 206.70K |
| Operating Income | 61.20K | -205.10K | 3.90K | -146.40K | -165.00K |
| Income Before Tax | 60.70K | -205.80K | -27.60K | -1.20M | -214.90K |
| Income Tax Expenses | 800.00 | -- | 0.00 | -- | 800.00 |
| Earnings from Continuing Operations | 59.90K | -205.80K | -27.60K | -1.20M | -215.70K |
| Earnings from Discontinued Operations | -- | -- | 0.00 | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.90K | -205.80K | -27.60K | -1.20M | -215.70K |
| EBIT | 61.20K | -205.10K | 3.90K | -146.40K | -165.00K |
| EBITDA | 61.30K | -205.00K | 4.10K | -146.40K | -164.70K |
| EPS Basic | 0.00 | -0.01 | 0.00 | -0.03 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | -0.03 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 38.01M | 38.01M | 38.01M | 38.01M | 38.01M |
| Average Diluted Shares Outstanding | 38.01M | 38.01M | 38.01M | 38.01M | 38.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |